BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 66.7% in March

BioSyent Inc. (OTCMKTS:BIOYF) saw a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 100 shares, a decline of 66.7% from the March 15th total of 300 shares. Based on an average daily trading volume, of 1,000 shares, the short-interest ratio is presently 0.1 days.

BioSyent Trading Up 4.3 %

BIOYF stock traded up $0.32 on Tuesday, reaching $7.70. 1,467 shares of the company were exchanged, compared to its average volume of 3,065. The stock’s fifty day moving average price is $7.67 and its 200 day moving average price is $7.84. BioSyent has a 12 month low of $5.93 and a 12 month high of $8.90.

BioSyent Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, March 3rd were given a dividend of $0.0347 per share. The ex-dividend date was Friday, February 28th. This is an increase from BioSyent’s previous dividend of $0.03. This represents a dividend yield of 1.77%.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.